Chemodex

7-Fluoro-2,1,3- benzoxadiazole-4-sulfonylchloride

As low as CHF 129.00
In stock
Only %1 left
CDX-F0577-M05050 mgCHF 129.00
CDX-F0577-M100100 mgCHF 483.00
NEW
 
More Information
Product Details
Synonyms CBD-F; 4-(Chlorosulfonyl)-7-fluoro-2,1,3-benzoxadiazole
Product Type Chemical
Properties
Formula C6H2ClFN2O3S
MW 236.61
CAS 91366-64-2
Source/Host Chemicals Synthetic
Purity Chemicals ≥95% (NMR)
Appearance Light orange solid.
Solubility Soluble in DMSO or chloroform.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ULAADSMIEGGGMT-UHFFFAOYSA-N
Smiles FC1=CC=C(S(=O)(Cl)=O)C2=NON=C21
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
4-(Chlorosulfonyl)-7-fluoro-2,1,3-benzoxadiazole is a versatile nucleophilic intermediate or building block for the synthesis of thiol-reactive fluorogenic probes, like ADB-F, SBD-F or DBD-F. It is characterized by its unique chlorosulfonyl group that enhances electrophilic reactivity. The presence of the fluorine atom increases the compound's polarity, promoting strong dipole interactions. This compound exhibits rapid reaction kinetics, particularly in nucleophilic substitution reactions, making it an intriguing subject for exploring mechanistic pathways and reactivity profiles in synthetic chemistry.
Product References
(1) T. Toyo'oka & K. Imai; Anal. Chem. 56, 2461 (1984) | (2) T. Toyo'oka, et al.; Analyst 114, 413 (1989) | (3) T. Toyo'oka, et al.; Analyst 114, 1233 (1989) | (4) T. Kajiro, et al.; Analyst 125, 1115 (2000) | (5) K. Okabe, et al.; J. Chromatogr. A 982, 111 (2002)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.